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codes observed in this study suggests
that in hospitals where influenza test-
ing is routinely performed, most
patients whose hospitalization sum-
mary includes an influenza-specific
ICD-9 code actually have influenza.
However, misclassification of patients
with parainfluenza and H. influenzae
infections as patients with influenza
demonstrates the potential for system-
atic coding errors even when influen-
za testing is routine. 
Epidemiologists and public health
officials should be aware that influen-
za-specific ICD-9 codes assigned in a
setting of routine rapid diagnostic
testing may be useful for following
trends. However, these codes will
substantially underestimate the actual
number of influenza-related hospital-
izations.
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Chikungunya Virus
Strains, Reunion
Island Outbreak
To the Editor: Chikungunya virus
(CHIKV) is endemic in rural tropical
Africa and is penetrating urban areas
in Asia. CHIKV is maintained in a
sylvatic cycle that involves mosqui-
toes of the genus Aedes, primates, and
rodents. CHIKV infection induces
fever, arthralgia, and maculopapular
rash. Hemorrhagic complications
have been reported in some outbreaks,
but a more specific symptom is severe
arthralgia, often persistent, which
results in long-lasting disability.
After numerous cases of CHIKV
infection had been reported in
Comoros and Mauritius (1), an out-
break of febrile illness was reported
on Reunion Island in March 2005 (2).
The incidence of the disease remained
relatively low until December 2005,
when it increased dramatically. The
outbreak resulted in >3,500 confirmed
cases and an estimated 250,000 sus-
pected cases (2), affecting >25% of
the island’s inhabitants. Encephalitic
forms were reported on many occa-
sions during the active phase of the
outbreak, and >200 persons died
while they were infected with
CHIKV. Previously unreported com-
plications, such as mother-to-child
transmission, myocarditis, hepatitis,
and extensive dermal lesions were
also encountered.
Many samples, collected from
patients during the outbreak, were
sent to our laboratory (Virology Unit,
Tropical Institute of the French
Armed Forces Medical Service,
Marseille, France) to identify the etio-
logic agent. Serum samples incubated
with C6/36 cells according to previ-
ously published methods (3) yielded
CHIKV. This virus was also isolated
from cerebrospinal fluid collected
from a patient with encephalitis, from
corneas collected from asymptomatic
human organ donors, and from pools
of mosquitoes (Aedes albopictus and
Culex quinquefasciatus) collected on
the island.
Five isolates were partially
sequenced. The CHIKV genome was
partly amplified by using the specific
primer pair OP16/OP17 (4), and
reverse transcription (RT)-PCR prod-
ucts (1,200 nucleotides long) were
cloned and sequenced (GenBank
accession nos. DQ462746–
DQ462750). Comparison of partialLETTERS
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sequences showed a high degree of
identity between the strains isolated in
Reunion, including the strain
LR2006_OPY1 (5): paired identity
was 99.3%–100% at the nucleotide
level and 98.2%–100% at the amino
acid level. The nucleotide and amino
acid substitutions were homogeneous-
ly distributed across the sequence and
were different for each isolate. Our
strain IMT/6470, isolated from human
serum, and the strain LR2006_OPY1
displayed the same nucleotide
sequence in the sequenced region.
The sequence identity among these
isolates highlights the common origin
of human and mosquito isolates.
The sequences of our isolates did
not feature any codon deletions or
insertions when compared with other
CHIKV isolates from Africa and Asia
available in GenBank (4,6). Strains
from Reunion were also compared
with the candidate vaccine strain TSI-
GSD-218 (7). This strain showed
93%–94% and 96%–97% identity at
the nucleotide and amino acid level,
respectively, which suggests a suffi-
cient antigenic community. Never-
theless, cross-neutralization experi-
ments are necessary to confirm the
protective effect of this candidate vac-
cine against Reunion strains.
In the phylogenetic tree based on
the partial E1 sequences (Figure), all
CHIKV strains isolated in Reunion
clustered together. These strains were
closely related to strains from the
Central African Republic and the
Democratic Republic of Congo (4,6).
This finding suggests that the bound-
aries of the Central African CHIKV
strains now extend to the Indian
Ocean. The phylogenetic tree also
illustrates the difference of lineage
between the Reunion Island isolates
and the Asian isolates.
CHIKV has been isolated from
Culex spp. collected during outbreaks
(8), but laboratory experiments have
shown that Cx. quinquefasciatus
failed to transmit CHIKV to monkeys
(9). Inside the Reunion cluster, the
strain from Culex spp. was localized
in a separate branch (bootstrap value
100%); this finding could be relevant
to the different role of these mosquito
species in virus epidemiology.
To our knowledge, CHIKV has
never been isolated from human
corneas. In our study, the cornea sam-
ple was obtained from an asympto-
matic donor whose serum contained
immunoglobulin M (IgM) but not IgG
to CHIKV; this finding suggests the
patient was recently infected with
CHIKV. The presence of CHIKV in
corneal cells will have to be con-
firmed because the samples we stud-
ied also included sclera, vascular tis-
sue that could contain circulating viri-
ons; however, no virus was detected
in the patient’s blood sample by
CHIKV-specific RT-PCR assay (10).
Infected corneal or scleral cells may
constitute a sanctuary that allows
virus to persist after virus is no longer
present in blood. Because viral per-
sistence, which could explain long-
lasting clinical complications of
CHIKV infection, has never been
demonstrated, this question deserves
more investigation.
Our results indicate that CHIKV
strains responsible for the outbreak in
Reunion have a common origin and
do not differ from strains circulating
in East and Central Africa. More com-
plete characterization of the 5 strains
we report here, sequencing of the full-
length genome, and phenotypic char-
acterization of other CHIKV isolated
in the area during the same period is
currently underway in our laboratory.
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Figure. Phylogenetic tree of chikungunya virus (CHIKV) based on partial nucleotide
sequences (3′ extremity of E1/3′ untranslated, position 10238–11367). Phylogram was
constructed with MEGA 2 (http://megasoftware.net/mega2.html), and the tree was drawn
with the Jukes-Cantor algorithm for genetic distance determination and the neighbor-join-
ing method. The percentage of successful bootstrap replicates (1,000 bootstrap replica-
tions, confidence probability >90%) is indicated at nodes. The length of branches is pro-
portional to the number of nucleotide changes (percentage of divergence). Asterisks (*)
indicate strains isolated in this study. The dark triangle corresponds to viruses of the
Democratic Republic of Congo clustering together (GenBank accession nos.
AY549575–AY549583). O’nyong-nyong virus (ONNV) sequence has been introduced for
correct rooting of the tree.LETTERS
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Legionnaires’
Disease and Travel
in Europe 
To the Editor: The European
Working Group for Legionella
Infections (EWGLINET) conducts
epidemiologic surveillance of
Legionnaires’ disease cases associat-
ed with travel (1) and provides epi-
demiologic typing markers of
Legionella pneumophila among refer-
ence laboratories in collaborating
countries. The procedures and criteria
of notification are found in the
Guidelines for Control and Prevention
of Travel Associated Legionnaires’
Disease (2). However, establishing
the association of >1 case of this dis-
ease and a specific tourist accommo-
dation site is difficult because of low
attack rates and dispersal of people
from the source of infection during
the incubation period.
Collaboration promoted by this
working group encourages the
exchange of data instead of cultures.
This distinction is critical when
research is conducted on travel-asso-
ciated Legionnaires’disease, in which
strains from patients and environmen-
tal sources of infection studied are in
different laboratories.
The value of such information is
shown in a complex case study that
was recently investigated. During July
and August 2005, two patients with
Legionnaire’s disease living in 2
countries in Europe were reported to
EWGLINET. Patient 1 was a 45-year-
old woman who traveled in France
and Spain July 1–6, 2005. Her symp-
toms started on July 6, 2005, when
she was in Girona, Spain, where she
was hospitalized. Patient 2 was a 56-
year-old woman who traveled in
Spain and France August 16–21,
2005. Her symptoms started on
August 8, 2005, when she was in
France, where she was hospitalized.
Both patients tested positive for L.
pneumophila serogroup 1 by specific
urinary antigen test and culture, but
they recovered and were discharged.
After routine notification to EWG-
LINET, it was established from the
list of accommodation sites provided
by the 2 patients that they each had
stayed for 1 night at the same hotel in
a French city within a 45-day interval.
This finding led us to identify a clus-
ter according to the definition in use
(2 cases associated with the same
accommodation within 2 years) (2).
However, patient 2 spent 1 day in
August in Zaragoza, Spain, during
which an outbreak of Legionnaires’
disease in the city affected 30 persons.
Thus, illness in patient 2 could have
been associated with the Zaragoza
outbreak. Alternatively, both patients
could have contracted the illness inde-
pendently at different sites. Before
onset, patient 1 stayed 5 days in her
private residence in Girona and
patient 2 visited 3 other hotels.
As soon as cultures from the 2
patients were available, the National
Reference Laboratories of France and
Spain shared their respective micro-